This is the only defence stock both FIIs and DIIs are still buying significantly, driven by its strong order book,…
While the bluechips and big names hog all the limelight in media, two recently listed smallcap underdogs are silently delivering…
Two companies have benefited greatly from the current IPO boom. These two finance companies help companies going public to meet…
Three clean energy stocks are gaining from rising demand, policy support, and capacity expansion. But high valuations and execution risks…
Spot freight rates in the key tanker segment have jumped over the past few weeks, given rising global oil production…
India’s EV race is shifting fast—early noise is fading, and these three real disruptors are emerging as scale, reliability, and…
Super investor, philanthropist and founder of ChrysCapital, Ashish Dhawan has 2 stocks in his portfolio that are delivering some solid…
Global jitters held Nifty back, but hidden market leaders are quietly preparing for their next big move. Three high-potential setups…
Strong growth in medical testing has benefited leading pathological laboratory chains. And two leading chains have recently declared bonus issues.…
India’s data centre buildout is creating new winners behind the scenes. Three quiet players linked to power, electrification, and cooling…
After years of being ignored, a select group of PSU leaders is entering a new phase of growth—where cleaner books,…
A new phase has begun in India’s food system, wherein value is being created as much in processing, packaging, and…
Auto ancillary stocks are trading close to their 52-week highs with a strong revival of demand for 2-wheeler and 4-wheeler…
The Big Whale of the market, Ashish Kacholia, seems to have already placed his bets for 2026. Two of his…
HAL wasn’t supposed to become India’s most lucrative defence manufacturer. Yet somewhere between old assembly sheds and new digital hangars,…
A 7% yield, cash-heavy balance sheet and hidden subsidiary value rarely come this cheap. Coal India’s valuation reflects decline, even…
Hospital stocks are viewed as “safe” as they are not subject to US FDA inspections and Trump rhetoric. Leading hospital…
PSBs have staged their strongest turnaround in a decade. Yet a few lenders still trade as if the cleanup never…